Logo image of AHR

AMERICAN HEALTHCARE REIT INC (AHR) Stock Fundamental Analysis

NYSE:AHR - New York Stock Exchange, Inc. - US3981823038 - REIT - Currency: USD

28.29  -0.5 (-1.74%)

After market: 28.29 0 (0%)

Fundamental Rating

2

AHR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of AHR have multiple concerns. AHR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AHR had negative earnings in the past year.
AHR had a positive operating cash flow in the past year.
AHR Yearly Net Income VS EBIT VS OCF VS FCFAHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 50M -50M 100M -100M

1.2 Ratios

The Return On Assets of AHR (-0.72%) is worse than 67.46% of its industry peers.
AHR has a worse Return On Equity (-1.52%) than 65.08% of its industry peers.
AHR's Return On Invested Capital of 2.35% is on the low side compared to the rest of the industry. AHR is outperformed by 60.32% of its industry peers.
AHR had an Average Return On Invested Capital over the past 3 years of 1.28%. This is in line with the industry average of 3.11%.
The last Return On Invested Capital (2.35%) for AHR is above the 3 year average (1.28%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.72%
ROE -1.52%
ROIC 2.35%
ROA(3y)-1.43%
ROA(5y)N/A
ROE(3y)-4.82%
ROE(5y)N/A
ROIC(3y)1.28%
ROIC(5y)N/A
AHR Yearly ROA, ROE, ROICAHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -2 -4

1.3 Margins

Looking at the Operating Margin, with a value of 6.26%, AHR is doing worse than 85.71% of the companies in the same industry.
AHR's Gross Margin of 20.00% is on the low side compared to the rest of the industry. AHR is outperformed by 94.44% of its industry peers.
Industry RankSector Rank
OM 6.26%
PM (TTM) N/A
GM 20%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AHR Yearly Profit, Operating, Gross MarginsAHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 5 10 15 20

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AHR is destroying value.
AHR has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, AHR has a worse debt to assets ratio.
AHR Yearly Shares OutstandingAHR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M
AHR Yearly Total Debt VS Total AssetsAHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

AHR has an Altman-Z score of 1.13. This is a bad value and indicates that AHR is not financially healthy and even has some risk of bankruptcy.
AHR has a Altman-Z score of 1.13. This is in the better half of the industry: AHR outperforms 76.98% of its industry peers.
AHR has a debt to FCF ratio of 743.75. This is a negative value and a sign of low solvency as AHR would need 743.75 years to pay back of all of its debts.
AHR has a Debt to FCF ratio of 743.75. This is comparable to the rest of the industry: AHR outperforms 41.27% of its industry peers.
AHR has a Debt/Equity ratio of 0.87. This is a neutral value indicating AHR is somewhat dependend on debt financing.
AHR has a better Debt to Equity ratio (0.87) than 67.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 743.75
Altman-Z 1.13
ROIC/WACC0.31
WACC7.5%
AHR Yearly LT Debt VS Equity VS FCFAHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

AHR has a Current Ratio of 0.61. This is a bad value and indicates that AHR is not financially healthy enough and could expect problems in meeting its short term obligations.
AHR has a Current ratio of 0.61. This is amonst the worse of the industry: AHR underperforms 82.54% of its industry peers.
AHR has a Quick Ratio of 0.61. This is a bad value and indicates that AHR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of AHR (0.61) is worse than 79.37% of its industry peers.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.61
AHR Yearly Current Assets VS Current LiabilitesAHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

AHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.87%, which is quite good.
Looking at the last year, AHR shows a quite strong growth in Revenue. The Revenue has grown by 13.60% in the last year.
EPS 1Y (TTM)11.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.98%
Revenue 1Y (TTM)13.6%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.83%

3.2 Future

The Earnings Per Share is expected to grow by 31.75% on average over the next years. This is a very strong growth
AHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.76% yearly.
EPS Next Y101.54%
EPS Next 2Y50.72%
EPS Next 3Y31.75%
EPS Next 5YN/A
Revenue Next Year9.78%
Revenue Next 2Y9.64%
Revenue Next 3Y8.76%
Revenue Next 5YN/A

3.3 Evolution

AHR Yearly Revenue VS EstimatesAHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
AHR Yearly EPS VS EstimatesAHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.5 -0.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AHR. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 105.70, which means the current valuation is very expensive for AHR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AHR is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.56, AHR is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 105.7
AHR Price Earnings VS Forward Price EarningsAHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AHR indicates a rather expensive valuation: AHR more expensive than 84.13% of the companies listed in the same industry.
AHR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 1678.97
EV/EBITDA 20.71
AHR Per share dataAHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
AHR's earnings are expected to grow with 31.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.72%
EPS Next 3Y31.75%

More info and screens

2

5. Dividend

5.1 Amount

AHR has a Yearly Dividend Yield of 3.47%.
Compared to an average industry Dividend Yield of 18.20, AHR is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.27, AHR pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.47%

5.2 History

AHR is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
AHR Yearly Dividends per shareAHR Yearly Dividends per shareYearly Dividends per share 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

AHR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-296.41%
EPS Next 2Y50.72%
EPS Next 3Y31.75%
AHR Yearly Income VS Free CF VS DividendAHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 0 50M -50M -100M

More info and screens

AMERICAN HEALTHCARE REIT INC

NYSE:AHR (1/31/2025, 8:10:02 PM)

After market: 28.29 0 (0%)

28.29

-0.5 (-1.74%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)02-27 2025-02-27/amc
Inst Owners51.39%
Inst Owner Change-0.48%
Ins Owners0.82%
Ins Owner Change-0.72%
Market Cap4.33B
Analysts81.67
Price Target32.77 (15.84%)
Short Float %6.04%
Short Ratio4.38
Dividend
Industry RankSector Rank
Dividend Yield 3.47%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-296.41%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.62%
Min Revenue beat(2)-1.61%
Max Revenue beat(2)6.85%
Revenue beat(4)3
Avg Revenue beat(4)1.68%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)6.85%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.47%
PT rev (3m)11.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)83.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-43.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.53%
Revenue NY rev (1m)-1.68%
Revenue NY rev (3m)1.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 105.7
P/S 2.15
P/FCF 1678.97
P/OCF 30.42
P/B 1.96
P/tB 2.41
EV/EBITDA 20.71
EPS(TTM)-0.47
EYN/A
EPS(NY)0.27
Fwd EY0.95%
FCF(TTM)0.02
FCFY0.06%
OCF(TTM)0.93
OCFY3.29%
SpS13.14
BVpS14.42
TBVpS11.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.72%
ROE -1.52%
ROCE 2.97%
ROIC 2.35%
ROICexc 2.39%
ROICexgc 2.68%
OM 6.26%
PM (TTM) N/A
GM 20%
FCFM 0.13%
ROA(3y)-1.43%
ROA(5y)N/A
ROE(3y)-4.82%
ROE(5y)N/A
ROIC(3y)1.28%
ROIC(5y)N/A
ROICexc(3y)1.3%
ROICexc(5y)N/A
ROICexgc(3y)1.47%
ROICexgc(5y)N/A
ROCE(3y)1.62%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 743.75
Debt/EBITDA 6.35
Cap/Depr 79.31%
Cap/Sales 6.95%
Interest Coverage 0.97
Cash Conversion 47.12%
Profit Quality N/A
Current Ratio 0.61
Quick Ratio 0.61
Altman-Z 1.13
F-Score6
WACC7.5%
ROIC/WACC0.31
Cap/Depr(3y)95.22%
Cap/Depr(5y)N/A
Cap/Sales(3y)9.68%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.98%
EPS Next Y101.54%
EPS Next 2Y50.72%
EPS Next 3Y31.75%
EPS Next 5YN/A
Revenue 1Y (TTM)13.6%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.83%
Revenue Next Year9.78%
Revenue Next 2Y9.64%
Revenue Next 3Y8.76%
Revenue Next 5YN/A
EBIT growth 1Y-15.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year442.37%
EBIT Next 3Y87.91%
EBIT Next 5YN/A
FCF growth 1Y-1644.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.32%
OCF growth 3YN/A
OCF growth 5YN/A